[1]
2024. Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology as a Parameter in Osteoporotic Rat Model. Majalah Kedokteran Bandung. 56, 3 (Sep. 2024), 197–202. DOI:https://doi.org/10.15395/mkb.v56.3016.